A 9-month-old baby who was born with a rare genetic disorder is the first person to be successfully treated with personalized CRISPR gene editing therapy, scientists in Philadelphia announced on Thursday.
The big picture: This "historic medical breakthrough" could "provide a pathway for gene editing technology to be successfully adapted to treat individuals with rare diseases for whom no medical treatments are available," per a statement from the University of Pennsylvania and the Children's Hospital of Philadelphia.
